DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Jim Cramer's Mad Dash: Good News for Regeneron

Trade-Ideas: Regeneron Pharmaceuticals (REGN) Is Today's Pre-Market Leader Stock

Sanofi And Regeneron Report Positive Top-Line Results From Nine Phase 3 Trials Of Alirocumab In Peop

Sanofi And Regeneron Report Positive Top-Line Results From Nine Phase 3 Trials Of Alirocumab In People With Hypercholesterolemia

3 Stocks Reiterated As A Buy: GM, DD, REGN

Regeneron Pharmaceuticals Inc Stock Upgraded (REGN)

REGN, ILMN And CELG, Pushing Health Care Sector Downward

5 Novartis Drugs You Need To Know About

Biogen (BIIB) and Regeneron (REGN) pose threats to Novartis' (NVS) sales as Diovan competitors launch.

Bayer/Regeneron Continue to Progress with Eylea - Analyst Blog

3 Stocks Reiterated As A Hold: NTAP, FSLR, REGN

InsiderInsights.com Daily Round Up: 7/17/14

See More Articles...